ROS1, along with epidermal growth factor receptor (EGFR) and anaplastic lymphoma kinase receptor tyrosine kinase (ALK) mutation, are clear driver genes for NSCLC [9]. This evidence concerns the gene EGFR and non-small cell lung carcinoma.